News
TKPHF
32.60
NaN%
--
FDA accepts Takeda’s application for intravenous Entyvio
TipRanks · 7h ago
Takeda to Issue Shares for Global Employee Long-Term Incentive Plan
TipRanks · 20h ago
Weekly Report: what happened at TKPHF last week (0601-0605)?
Weekly Report · 1d ago
Takeda Books ¥402.5bn Legal Provision but Keeps FY2026 Outlook Intact
TipRanks · 4d ago
TD Cowen Sticks to Its Buy Rating for Takeda Pharmaceutical Company (TAK)
TipRanks · 5d ago
Takeda Pharmaceutical Co (TKPHF) Gets a Buy from Morgan Stanley
TipRanks · 6d ago
Weekly Report: what happened at TKPHF last week (0525-0529)?
Weekly Report · 06/01 10:06
Takeda Files New Japan Shelf Registration to Support Long-Term Incentive Plan
TipRanks · 06/01 07:52
Innovent Biologics announces results from PoC study of IBI363
TipRanks · 06/01 00:45
Weekly Report: what happened at TKPHF last week (0518-0522)?
Weekly Report · 05/25 10:09
Takeda Ordered To Pay $884.9 Mln In AMITIZA Antitrust Case; To Revise FY25 Results
NASDAQ · 05/19 05:30
Takeda faces major AMITIZA antitrust verdict and prepares FY2025 provision
TipRanks · 05/19 01:52
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
TipRanks · 05/18 19:25
Takeda told to pay hundreds of millions for generic drug delay, Bloomberg says
TipRanks · 05/18 18:35
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
TipRanks · 05/18 18:31
Weekly Report: what happened at TKPHF last week (0511-0515)?
Weekly Report · 05/18 10:09
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
TipRanks · 05/15 14:25
Justice Department announces $13.67M civil settlement with Takeda
TipRanks · 05/14 20:19
Takeda Extends Long-Term Stock Incentive Plans for Directors and Management into 2026
TipRanks · 05/13 09:09
Takeda Lifts Profit and Dividend Despite Revenue Dip, Signals Softer Earnings Ahead
TipRanks · 05/13 07:33
More
Webull provides a variety of real-time TKPHF stock news. You can receive the latest news about Takeda Pharmaceutical Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TKPHF
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.